发明授权
US09156886B2 Cyclosporin analogues for preventing or treating hepatitis C infection
有权
用于预防或治疗丙型肝炎感染的环孢菌素类似物
- 专利标题： Cyclosporin analogues for preventing or treating hepatitis C infection
- 专利标题（中）： 用于预防或治疗丙型肝炎感染的环孢菌素类似物
-
申请号： US13734074申请日： 2013-01-04
-
公开(公告)号： US09156886B2公开(公告)日： 2015-10-13
- 发明人: Yat Sun Or , Guoqiang Wang , Jiang Long , Xuri Gao
- 申请人： Enanta Pharmaceuticals, Inc.
- 申请人地址： US MA Watertown
- 专利权人： Enanta Pharmaceuticals, Inc.
- 当前专利权人： Enanta Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Watertown
- 代理机构： Elmore Patent Law Group P.C.
- 代理商 Edgar W. Harlan; Carolyn S. Elmore, Esq.
- 主分类号： A61K38/13
- IPC分类号： A61K38/13 ; A01N37/18 ; A61K38/00 ; A61P31/12 ; A61K31/18 ; C07K7/52 ; A61K31/7088 ; A61K38/21 ; A61K45/00
摘要：
The present invention relates to cyclosporin analogues having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporin analogue compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
公开/授权文献
信息查询
IPC分类:
